Anuh Pharma Ltd. benchmarking: Perfomance to industry peers

Financial

	Anuh Pharma	Ind-Swift Lab.	Bharat Parenterals
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	0.0	2.9 %	0.31 %
Financials
5 yr Average ROE	15.87 %	14.53 %	7.88 %
5yr average Equity Multiplier	1.62	2.17	1.84
5yr Average Asset Turnover Ratio	1.35	0.66	0.73
5yr Avg Net Profit Margin	7.23 %	16.17 %	5.85 %
Price to Book	2.43	0.61	2.35
P/E	20.55	3.32	0.0
5yr Avg Cash Conversion Cycle	42.81 Days	15.71 Days	107.3 Days
Inventory Days	50.87 Days	103.91 Days	52.36 Days
Days Receivable	111.12 Days	105.66 Days	167.45 Days
Days Payable	117.6 Days	107.02 Days	103.87 Days
5yr Average Interest Coverage Ratio	48.66	21.19	14.58
5yr Avg ROCE	21.17 %	12.09 %	9.5 %
5yr Avg Operating Profit Margin	10.21 %	14.94 %	9.16 %
5 yr average Debt to Equity	0.02	0.91	0.36
5yr CAGR Net Profit	10.73 %	n/a	n/a
5yr Average Return on Assets	9.84 %	11.49 %	5.04 %
Shareholdings
Promoter Holding	71.82 %	39.5 %	67.19 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.23 %	-2.5 %	-6.65 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Anuh Pharma	Ind-Swift Lab.	Bharat Parenterals
Product Wise Break-Up	Product Wise Break-Up Bulk drug and Chemicals 100.0 Pharmaceuticals 0	Product Wise Break-Up Bulk drug and Chemicals 0 Pharmaceutical 100.0	Product Wise Break-Up Bulk drug and Chemicals 0 Pharmaceutical 100.0
Location Wise Break-Up	Location Wise Break-Up India 45.02 Rest of the World 0 Others 54.98	Location Wise Break-Up Rest of the World 0 India 27.72 Others 72.28	Location Wise Break-Up Rest of the World 76.17 India 23.83
Brand Wise Break-Up	Brand Wise Break-Up Erythromycin 33.38 Cortico Steroids 15.41 Higher Macrolides 14.5 Sulphadoxine 13.6 Pyrazinamide 5.74 Chloramhenicol 4.98 Gliclazide 4.23 Ambroxol HCL 3.02 Others 5.14	-	-